Your browser doesn't support javascript.
loading
Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma.
Martin, Brice; Garman, Tyler; Laramee, Madeline; Wang, Amy; Zhang, Xiaohu; Beck, Erin; Wilson, Kelli; Klumpp-Thomas, Carleen; McKnight, Crystal; Xu, Xin; Hagen, Natalie; Holland, David; Dahmane, Nadia; Thomas, Craig J; Souweidane, Mark.
Afiliação
  • Martin B; Department of Neurological Surgery, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: brm4007@med.cornell.edu.
  • Garman T; Department of Neurological Surgery, Weill Cornell Medicine, New York, NY 10065, USA.
  • Laramee M; Department of Neurological Surgery, Weill Cornell Medicine, New York, NY 10065, USA.
  • Wang A; Division of National Toxicology, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA.
  • Zhang X; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA.
  • Beck E; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA.
  • Wilson K; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA.
  • Klumpp-Thomas C; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA.
  • McKnight C; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA.
  • Xu X; Division of National Toxicology, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA.
  • Hagen N; Division of National Toxicology, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA.
  • Holland D; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Dahmane N; Department of Neurological Surgery, Weill Cornell Medicine, New York, NY 10065, USA.
  • Thomas CJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Souweidane M; Department of Neurological Surgery, Weill Cornell Medicine, New York, NY 10065, USA; Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
J Control Release ; 357: 580-590, 2023 05.
Article em En | MEDLINE | ID: mdl-37054779
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Neoplasias do Plexo Corióideo Limite: Animals / Child / Humans Idioma: En Revista: J Control Release Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Neoplasias do Plexo Corióideo Limite: Animals / Child / Humans Idioma: En Revista: J Control Release Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de publicação: Holanda